Please enable JavaScript to continue using this application.

Compare $AZTA vs $DNA | Chartloom

Compare

$AZTA vs $DNA

Azenta Inc · Ginkgo Bioworks Holdings Inc

AZTA

Azenta Inc

DNA

Ginkgo Bioworks Holdings Inc

Compare $AZTA vs $DNA

Comparing Azenta Inc and Ginkgo Bioworks Holdings Inc

AZTAAzenta Inc

DNAGinkgo Bioworks Holdings Inc

AZTAAzenta Inc

Market cap

$1.74B

P/E (TTM)

—

Forward P/E (NTM)

66.47x

Forward P/S (NTM)

2.69x

Rev growth (TTM)

1.4%

YTD performance

13.0%

52W performance

17.0%

FCF yield

0.6%

DNAGinkgo Bioworks Holdings Inc

Market cap

$810M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-51.5%

YTD performance

49.4%

52W performance

-19.2%

FCF yield

-21.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

AZTA

DNA

Detailed metrics comparison

AZTA

Azenta Inc

DNA

Ginkgo Bioworks Holdings Inc

Market Cap

AZTA$1.74B

DNA$810M

Enterprise Value

AZTA$1.55B

DNA$726M

Price

AZTA$37.72

DNA$13.00

P/E Ratio

AZTAN/A

DNAN/A

P/S Ratio

AZTA2.83x

DNA7.24x

EV/Sales

AZTA2.52x

DNA6.49x

EV/EBITDA

AZTA37.55x

DNA0.00x

P/B Ratio

AZTA1.12x

DNA1.98x

P/FCF Ratio

AZTA175.95x

DNAN/A

EV/FCF

AZTA156.75x

DNA-4.15x

PEG Ratio

AZTAN/A

DNAN/A

Forward P/E (NTM)

AZTA66.47x

DNAN/A

Forward P/S (NTM)

AZTA2.69x

DNAN/A

Revenue (TTM)

AZTA$614M

DNA$112M

Revenue Growth (YoY)

AZTA1.4%

DNA-51.5%

Forward Rev Growth

AZTA5.4%

DNA13.4%

Gross Margin (TTM)

AZTA43.4%

DNA77.7%

Operating Margin (TTM)

AZTA0.0%

DNA0.0%

EBITDA Margin (TTM)

AZTA5.3%

DNA-210.7%

Net Margin (TTM)

AZTA-20.0%

DNA-260.0%

FCF Margin (TTM)

AZTA1.6%

DNA-156.3%

Net Income (TTM)

AZTA$-123M

DNA$-291M

FCF (TTM)

AZTA$10M

DNA$-175M

EPS (TTM)

AZTA-$2.71

DNA-$4.68

ROE (TTM)

AZTA-756.0%

DNA-6021.0%

ROA (TTM)

AZTA-621.0%

DNA-2685.0%

ROIC (TTM)

AZTA-756.0%

DNA-6021.0%

Cash

AZTA$190M

DNA$85M

Debt

AZTA$0

DNA$0

Net Cash/Debt

AZTA$190M

DNA$85M

Current Ratio (TTM)

AZTA2.50x

DNA4.57x

Quick Ratio (TTM)

AZTA2.12x

DNA4.37x

Debt/Equity (TTM)

AZTA0.00x

DNA0.00x

Debt/Assets (TTM)

AZTA0.0%

DNA0.0%

Interest Coverage (TTM)

AZTAN/A

DNAN/A

Net Debt/EBITDA (TTM)

AZTA0.00x

DNA0.00x

Beta

AZTA1.51

DNA1.69

52W Performance

AZTA17.0%

DNA-19.2%

YTD Performance

AZTA13.0%

DNA49.4%

% from 52W High

AZTA-18.7%

DNA-28.6%

% from 52W Low

AZTA136.8%

DNA142.1%

Asset Turnover (TTM)

AZTA0.31x

DNA0.10x

FCF Yield (TTM)

AZTA0.6%

DNA-21.6%

Earnings Yield (TTM)

AZTA-7.1%

DNA-35.9%

Dividend Yield (TTM)

AZTAN/A

DNAN/A

Rule of 40

AZTA3.0

DNA-207.8

EV/GP/RG

AZTA0.83

DNA0.42

Ticker research

View AZTA research View DNA research

Metric	AZTA Azenta Inc	DNA Ginkgo Bioworks Holdings Inc
Market & Valuation
Market Cap	$1.74B	$810M
Enterprise Value	$1.55B	$726M
Price	$37.72	$13.00
P/E Ratio	N/A	N/A
P/S Ratio	2.83x	7.24x
EV/Sales	2.52x	6.49x
EV/EBITDA	37.55x	0.00x
P/B Ratio	1.12x	1.98x
P/FCF Ratio	175.95x	N/A
EV/FCF	156.75x	-4.15x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	66.47x	N/A
Forward P/S (NTM)	2.69x	N/A
Revenue & Growth
Revenue (TTM)	$614M	$112M
Revenue Growth (YoY)	1.4%	-51.5%
Forward Rev Growth	5.4%	13.4%
Profitability
Gross Margin (TTM)	43.4%	77.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	5.3%	-210.7%
Net Margin (TTM)	-20.0%	-260.0%
FCF Margin (TTM)	1.6%	-156.3%
Net Income (TTM)	$-123M	$-291M
FCF (TTM)	$10M	$-175M
EPS (TTM)	-$2.71	-$4.68
ROE (TTM)	-756.0%	-6021.0%
ROA (TTM)	-621.0%	-2685.0%
ROIC (TTM)	-756.0%	-6021.0%
Financial Health
Cash	$190M	$85M
Debt	$0	$0
Net Cash/Debt	$190M	$85M
Current Ratio (TTM)	2.50x	4.57x
Quick Ratio (TTM)	2.12x	4.37x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.51	1.69
52W Performance	17.0%	-19.2%
YTD Performance	13.0%	49.4%
% from 52W High	-18.7%	-28.6%
% from 52W Low	136.8%	142.1%
Efficiency & Yields
Asset Turnover (TTM)	0.31x	0.10x
FCF Yield (TTM)	0.6%	-21.6%
Earnings Yield (TTM)	-7.1%	-35.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	3.0	-207.8
EV/GP/RG	0.83	0.42
Ticker research	View AZTA research	View DNA research

Valuation

P/S Ratio

AZTA

2.83x

DNA

7.24x

EV/FCF

DNA

-4.15x

AZTA

156.75x

Growth & revenue

Revenue Growth TTM

AZTA

1.4%

DNA

-51.5%

Forward Revenue Growth

DNA

13.4%

AZTA

5.4%

Profitability & performance

Gross Margin

DNA

77.7%

AZTA

43.4%

ROE

AZTA

-756.0%

DNA

-6021.0%

FCF Yield %

AZTA

0.6%

DNA

-21.6%

52-Week Performance

AZTA

17.0%

DNA

-19.2%

Detailed metrics comparison

AZTA

Azenta Inc

DNA

Ginkgo Bioworks Holdings Inc

Market Cap

AZTA$1.74B

DNA$810M

Enterprise Value

AZTA$1.55B

DNA$726M

Price

AZTA$37.72

DNA$13.00

P/E Ratio

AZTAN/A

DNAN/A

P/S Ratio

AZTA2.83x

DNA7.24x

EV/Sales

AZTA2.52x

DNA6.49x

EV/EBITDA

AZTA37.55x

DNA0.00x

P/B Ratio

AZTA1.12x

DNA1.98x

P/FCF Ratio

AZTA175.95x

DNAN/A

EV/FCF

AZTA156.75x

DNA-4.15x

PEG Ratio

AZTAN/A

DNAN/A

Forward P/E (NTM)

AZTA66.47x

DNAN/A

Forward P/S (NTM)

AZTA2.69x

DNAN/A

Revenue (TTM)

AZTA$614M

DNA$112M

Revenue Growth (YoY)

AZTA1.4%

DNA-51.5%

Forward Rev Growth

AZTA5.4%

DNA13.4%

Gross Margin (TTM)

AZTA43.4%

DNA77.7%

Operating Margin (TTM)

AZTA0.0%

DNA0.0%

EBITDA Margin (TTM)

AZTA5.3%

DNA-210.7%

Net Margin (TTM)

AZTA-20.0%

DNA-260.0%

FCF Margin (TTM)

AZTA1.6%

DNA-156.3%

Net Income (TTM)

AZTA$-123M

DNA$-291M

FCF (TTM)

AZTA$10M

DNA$-175M

EPS (TTM)

AZTA-$2.71

DNA-$4.68

ROE (TTM)

AZTA-756.0%

DNA-6021.0%

ROA (TTM)

AZTA-621.0%

DNA-2685.0%

ROIC (TTM)

AZTA-756.0%

DNA-6021.0%

Cash

AZTA$190M

DNA$85M

Debt

AZTA$0

DNA$0

Net Cash/Debt

AZTA$190M

DNA$85M

Current Ratio (TTM)

AZTA2.50x

DNA4.57x

Quick Ratio (TTM)

AZTA2.12x

DNA4.37x

Debt/Equity (TTM)

AZTA0.00x

DNA0.00x

Debt/Assets (TTM)

AZTA0.0%

DNA0.0%

Interest Coverage (TTM)

AZTAN/A

DNAN/A

Net Debt/EBITDA (TTM)

AZTA0.00x

DNA0.00x

Beta

AZTA1.51

DNA1.69

52W Performance

AZTA17.0%

DNA-19.2%

YTD Performance

AZTA13.0%

DNA49.4%

% from 52W High

AZTA-18.7%

DNA-28.6%

% from 52W Low

AZTA136.8%

DNA142.1%

Asset Turnover (TTM)

AZTA0.31x

DNA0.10x

FCF Yield (TTM)

AZTA0.6%

DNA-21.6%

Earnings Yield (TTM)

AZTA-7.1%

DNA-35.9%

Dividend Yield (TTM)

AZTAN/A

DNAN/A

Rule of 40

AZTA3.0

DNA-207.8

EV/GP/RG

AZTA0.83

DNA0.42

Ticker research

View AZTA research View DNA research

Metric	AZTA Azenta Inc	DNA Ginkgo Bioworks Holdings Inc
Market & Valuation
Market Cap	$1.74B	$810M
Enterprise Value	$1.55B	$726M
Price	$37.72	$13.00
P/E Ratio	N/A	N/A
P/S Ratio	2.83x	7.24x
EV/Sales	2.52x	6.49x
EV/EBITDA	37.55x	0.00x
P/B Ratio	1.12x	1.98x
P/FCF Ratio	175.95x	N/A
EV/FCF	156.75x	-4.15x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	66.47x	N/A
Forward P/S (NTM)	2.69x	N/A
Revenue & Growth
Revenue (TTM)	$614M	$112M
Revenue Growth (YoY)	1.4%	-51.5%
Forward Rev Growth	5.4%	13.4%
Profitability
Gross Margin (TTM)	43.4%	77.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	5.3%	-210.7%
Net Margin (TTM)	-20.0%	-260.0%
FCF Margin (TTM)	1.6%	-156.3%
Net Income (TTM)	$-123M	$-291M
FCF (TTM)	$10M	$-175M
EPS (TTM)	-$2.71	-$4.68
ROE (TTM)	-756.0%	-6021.0%
ROA (TTM)	-621.0%	-2685.0%
ROIC (TTM)	-756.0%	-6021.0%
Financial Health
Cash	$190M	$85M
Debt	$0	$0
Net Cash/Debt	$190M	$85M
Current Ratio (TTM)	2.50x	4.57x
Quick Ratio (TTM)	2.12x	4.37x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.51	1.69
52W Performance	17.0%	-19.2%
YTD Performance	13.0%	49.4%
% from 52W High	-18.7%	-28.6%
% from 52W Low	136.8%	142.1%
Efficiency & Yields
Asset Turnover (TTM)	0.31x	0.10x
FCF Yield (TTM)	0.6%	-21.6%
Earnings Yield (TTM)	-7.1%	-35.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	3.0	-207.8
EV/GP/RG	0.83	0.42
Ticker research	View AZTA research	View DNA research